Boruban, CemYavaş, ÖzlemAltundağ, Muzaffer BedriAltundağ, Kadri2020-03-262020-03-2620050306-98771532-2777https://dx.doi.org/10.1016/j.mehy.2005.04.004https://hdl.handle.net/20.500.12395/19764[Abstract not Available]en10.1016/j.mehy.2005.04.004info:eu-repo/semantics/openAccessImatinib may be useful in the management of patients with glioblastomaLetter6561205120616109460Q2WOS:000232865400045Q4